TG Therapeutics Inc. (TGTX) NASDAQ
$27 0.51 (1.93%)
Market Cap: $3.96B
As of 06/07/23 04:00 PM EDT. Market closed.
TG Therapeutics Inc. (TGTX)
NASDAQ
$27
0.51 (1.93%)
Market Cap: $3.96B
As of 06/07/23 04:00 PM EDT. Market closed.
TG Therapeutics is a fully-integrated, commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. In addition to an active research pipeline including five investigational medicines across these therapeutic areas, TG has received accelerated approval from the U.S. FDA for UKONIQTM ... read more
TG Therapeutics is a fully-integrated, commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. In addition to an active research pipeline including five investigational medicines across these therapeutic areas, TG has received accelerated approval from the U.S. FDA for UKONIQTM (umbralisib), for the treatment of adult patients with relapsed/refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed/refractory follicular lymphoma who have received at least three prior lines of systemic therapies. Currently, the Company has two programs in Phase 3 development for the treatment of patients with relapsing forms of multiple sclerosis (RMS) and patients with chronic lymphocytic leukemia (CLL) and several investigational medicines in Phase 1 clinical development. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Weiss
Full Time Employees
286
CEO Compensation (Base)
$655,625
CEO Compensation (Total)
$14.30M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Weiss
Full Time Employees
286
CEO Compensation (Base)
$655,625
CEO Compensation (Total)
$14.30M
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
PRICE CHART FOR TG THERAPEUTICS INC
From:
To:
NEWS
KEY STATS
Open
$26.57
Previous Close
$26.49
Days Range
$25.71 - $27.73
52 week range
$3.48 - $35.67
Volume
3,244,263
Avg. Volume (30 days)
3,324,665
Market Cap
$3.96B
Dividend Yield
0.00%
P/E
-23.48
Shares Outstanding
149,396,038
Open
$26.57
Previous Close
$26.49
Days Range
$25.71 - $27.73
52 week range
$3.48 - $35.67
Volume
3,244,263
Avg. Volume (30 days)
3,324,665
Market Cap
$3.96B
Dividend Yield
0.00%
P/E
-23.48
Shares Outstanding
149,396,038
Open in: 
Open in:
INSIDER TRANSACTIONS FOR TG THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Power Sean A | Chief Financial Officer | Jun 02, 2023 | Sale | $26.70 | 73,647 | 1,966,375 | 654,836 | Jun 05, 2023, 06:26 PM |
| Echelard Yann | Director | Jan 06, 2023 | Buy | $10.64 | 9,000 | 95,760 | 201,848 | Jan 06, 2023, 05:01 PM |
| Charney Laurence N | Director | Jan 04, 2023 | Sale | $11.10 | 30,000 | 333,000 | 234,729 | Jan 06, 2023, 05:00 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jan 05, 2022 | Sale | $18.31 | 9,653 | 176,746 | 568,483 | Jan 07, 2022, 06:11 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jan 04, 2022 | Sale | $19.20 | 75,312 | 1,445,990 | 578,136 | Jan 07, 2022, 06:11 PM |
| WEISS MICHAEL S | CEO and President | Jan 05, 2022 | Sale | $18.31 | 30,671 | 561,586 | 10,988,021 | Jan 07, 2022, 06:00 PM |
| WEISS MICHAEL S | CEO and President | Jan 04, 2022 | Sale | $19.20 | 37,549 | 720,941 | 13,455,697 | Jan 07, 2022, 06:00 PM |
| Echelard Yann | Director | Dec 10, 2020 | Sale | $40.05 | 30,000 | 1,201,500 | 129,116 | Dec 11, 2020, 05:01 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sep 09, 2020 | Sale | $25.81 | 158,589 | 4,092,738 | 12,629,868 | Sep 11, 2020, 04:31 PM |
| KENNEDY WILLIAM JAMES | Director | Jun 17, 2020 | Sale | $18.27 | 7,745 | 141,501 | 94,633 | Jun 24, 2020, 07:48 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jul 01, 2019 | Sale | $8.47 | 17,654 | 149,529 | 383,338 | Jul 03, 2019, 04:00 PM |
| WEISS MICHAEL S | CEO and President | Jun 26, 2019 | Buy | $7.03 | 50,000 | 351,750 | 12,878,185 | Jun 27, 2019, 07:33 AM |
| Power Sean A | CFO, Secretary and Treasurer | Jan 02, 2019 | Sale | $4.13 | 37,275 | 153,946 | 400,992 | Jan 03, 2019, 07:21 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jul 02, 2018 | Sale | $13.26 | 12,191 | 161,653 | 473,267 | Jul 05, 2018, 05:00 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jul 03, 2018 | Sale | $13.19 | 35,000 | 461,650 | 438,267 | Jul 05, 2018, 05:00 PM |
| KENNEDY WILLIAM JAMES | Director | Jun 14, 2018 | Sale | $13.45 | 25,071 | 337,205 | 60,330 | Jun 18, 2018, 04:30 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jan 02, 2018 | Sale | $8.50 | 32,006 | 272,051 | 485,458 | Jan 03, 2018, 05:25 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jun 19, 2017 | Sale | $11.04 | 30,000 | 331,200 | 447,464 | Jun 19, 2017, 06:05 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jun 16, 2017 | Sale | $11.14 | 29,976 | 333,933 | 477,464 | Jun 19, 2017, 06:05 PM |
| KENNEDY WILLIAM JAMES | Director | Apr 11, 2017 | Sale | $10.27 | 8,548 | 87,788 | 70,401 | Apr 12, 2017, 05:44 PM |
| Charney Laurence N | Director | Apr 04, 2017 | Sale | $11.17 | 7,000 | 78,190 | 88,949 | Apr 04, 2017, 05:57 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jan 04, 2017 | Sale | $4.55 | 8,816 | 40,113 | 507,440 | Jan 04, 2017, 05:28 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jul 05, 2016 | Sale | $5.99 | 50,426 | 302,052 | 416,256 | Jul 08, 2016, 08:06 PM |
| Power Sean A | CFO, Secretary and Treasurer | Apr 18, 2016 | Sale | $10.12 | 10,000 | 101,200 | 466,682 | Apr 20, 2016, 05:00 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jan 05, 2016 | Sale | $11.21 | 22,790 | 255,476 | 476,682 | Jan 07, 2016, 06:00 PM |
| KENNEDY WILLIAM JAMES | Director | Jul 08, 2015 | Sale | $17.08 | 17,000 | 290,360 | 66,490 | Jul 09, 2015, 09:41 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jul 01, 2015 | Sale | $16.46 | 50,054 | 823,889 | 449,472 | Jul 02, 2015, 05:00 PM |
| LFB Biotechnologies S.A.S.U. | 10% Owner | Feb 17, 2015 | Buy | $6.53 | 114,855 | 750,003 | 5,114,855 | May 11, 2015, 04:30 PM |
| LFB Biotechnologies S.A.S.U. | 10% Owner | May 07, 2015 | Option Exercise | $0.00 | 2,500,000 | 2,500 | 7,614,855 | May 11, 2015, 04:30 PM |
| Power Sean A | CFO, Secretary and Treasurer | Apr 02, 2015 | Sale | $15.51 | 11,000 | 170,610 | 499,526 | Apr 03, 2015, 05:00 PM |
| Power Sean A | CFO, Secretary and Treasurer | Apr 01, 2015 | Sale | $15.50 | 12,800 | 198,400 | 510,526 | Apr 03, 2015, 05:00 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jan 05, 2015 | Sale | $16.40 | 54,057 | 886,448 | 535,670 | Jan 07, 2015, 08:50 PM |
| Power Sean A | CFO, Secretary and Treasurer | Jan 07, 2015 | Sale | $16.40 | 12,344 | 202,442 | 523,326 | Jan 07, 2015, 08:50 PM |
| WEISS MICHAEL S | See Remarks | Dec 16, 2014 | Sale | $16.44 | 210,618 | 3,462,560 | 8,120,773 | Dec 18, 2014, 09:44 PM |
| Power Sean A | CFO, Secretary and Treasurer | Dec 16, 2014 | Sale | $16.44 | 38,041 | 625,394 | 579,727 | Dec 18, 2014, 09:37 PM |
| Power Sean A | CFO, Secretary and Treasurer | Nov 21, 2013 | Option Exercise | $5.38 | 23,106 | 124,310 | 542,768 | Jan 02, 2014, 07:00 PM |
| WEISS MICHAEL S | See Remarks | Dec 11, 2013 | Buy | $3.43 | 10,000 | 34,300 | 7,839,471 | Dec 12, 2013, 06:06 AM |
| Power Sean A | CFO, Secretary and Treasurer | May 17, 2012 | Option Exercise | $6.25 | 13,526 | 84,538 | 490,874 | Jan 02, 2013, 08:11 PM |
| Herskowitz Neil | Director | Dec 06, 2012 | Buy | $2.00 | 1,000 | 2,000 | 51,265 | Dec 12, 2012, 04:30 PM |
| Power Sean A | CFO, Secretary and Treasurer | Sep 14, 2012 | Buy | $2.28 | 3,400 | 7,752 | 504,400 | Sep 17, 2012, 09:46 AM |
| Power Sean A | CFO, Secretary and Treasurer | Sep 13, 2012 | Buy | $2.25 | 1,000 | 2,250 | 501,000 | Sep 17, 2012, 09:46 AM |
| WEISS MICHAEL S | See Remarks | Sep 11, 2012 | Buy | $2.25 | 100,000 | 225,000 | 7,342,728 | Sep 11, 2012, 04:01 PM |
| WEISS MICHAEL S | See Remarks | Sep 10, 2012 | Buy | $2.25 | 50,000 | 112,500 | 7,242,728 | Sep 11, 2012, 04:01 PM |
| WEISS MICHAEL S | See Remarks | May 16, 2012 | Buy | $6.25 | 1,500 | 9,375 | 5,192,728 | May 17, 2012, 05:32 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Power Sean A | Chief Financial Officer | 06/02/2023 | 1,966,375 |
| Echelard Yann | Director | 01/06/2023 | 95,760 |
| Charney Laurence N | Director | 01/04/2023 | 333,000 |
| Power Sean A | CFO, Secretary and Treasurer | 01/05/2022 | 176,746 |
| Power Sean A | CFO, Secretary and Treasurer | 01/04/2022 | 1,445,990 |
| WEISS MICHAEL S | CEO and President | 01/05/2022 | 561,586 |
| WEISS MICHAEL S | CEO and President | 01/04/2022 | 720,941 |
| Echelard Yann | Director | 12/10/2020 | 1,201,500 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 09/09/2020 | 4,092,738 |
| KENNEDY WILLIAM JAMES | Director | 06/17/2020 | 141,501 |
| Power Sean A | CFO, Secretary and Treasurer | 07/01/2019 | 149,529 |
| WEISS MICHAEL S | CEO and President | 06/26/2019 | 351,750 |
| Power Sean A | CFO, Secretary and Treasurer | 01/02/2019 | 153,946 |
| Power Sean A | CFO, Secretary and Treasurer | 07/02/2018 | 161,653 |
| Power Sean A | CFO, Secretary and Treasurer | 07/03/2018 | 461,650 |
| KENNEDY WILLIAM JAMES | Director | 06/14/2018 | 337,205 |
| Power Sean A | CFO, Secretary and Treasurer | 01/02/2018 | 272,051 |
| Power Sean A | CFO, Secretary and Treasurer | 06/19/2017 | 331,200 |
| Power Sean A | CFO, Secretary and Treasurer | 06/16/2017 | 333,933 |
| KENNEDY WILLIAM JAMES | Director | 04/11/2017 | 87,788 |
| Charney Laurence N | Director | 04/04/2017 | 78,190 |
| Power Sean A | CFO, Secretary and Treasurer | 01/04/2017 | 40,113 |
| Power Sean A | CFO, Secretary and Treasurer | 07/05/2016 | 302,052 |
| Power Sean A | CFO, Secretary and Treasurer | 04/18/2016 | 101,200 |
| Power Sean A | CFO, Secretary and Treasurer | 01/05/2016 | 255,476 |
| KENNEDY WILLIAM JAMES | Director | 07/08/2015 | 290,360 |
| Power Sean A | CFO, Secretary and Treasurer | 07/01/2015 | 823,889 |
| LFB Biotechnologies S.A.S.U. | 10% Owner | 02/17/2015 | 750,003 |
| LFB Biotechnologies S.A.S.U. | 10% Owner | 05/07/2015 | 2,500 |
| Power Sean A | CFO, Secretary and Treasurer | 04/02/2015 | 170,610 |
| Power Sean A | CFO, Secretary and Treasurer | 04/01/2015 | 198,400 |
| Power Sean A | CFO, Secretary and Treasurer | 01/05/2015 | 886,448 |
| Power Sean A | CFO, Secretary and Treasurer | 01/07/2015 | 202,442 |
| WEISS MICHAEL S | See Remarks | 12/16/2014 | 3,462,560 |
| Power Sean A | CFO, Secretary and Treasurer | 12/16/2014 | 625,394 |
| Power Sean A | CFO, Secretary and Treasurer | 11/21/2013 | 124,310 |
| WEISS MICHAEL S | See Remarks | 12/11/2013 | 34,300 |
| Power Sean A | CFO, Secretary and Treasurer | 05/17/2012 | 84,538 |
| Herskowitz Neil | Director | 12/06/2012 | 2,000 |
| Power Sean A | CFO, Secretary and Treasurer | 09/14/2012 | 7,752 |
| Power Sean A | CFO, Secretary and Treasurer | 09/13/2012 | 2,250 |
| WEISS MICHAEL S | See Remarks | 09/11/2012 | 225,000 |
| WEISS MICHAEL S | See Remarks | 09/10/2012 | 112,500 |
| WEISS MICHAEL S | See Remarks | 05/16/2012 | 9,375 |
Load More Insider Transactions
FUNDS WITH A POSITION IN TG THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 8,849,700 | 0.00393% | -3.11% | Other |
| MAVERICK CAPITAL LTD | 4,318,700 | 1.21% | Exited | Growth At A Reasonable Price, Growth |
| GEODE CAPITAL MANAGEMENT, LLC | 2,679,800 | 0.00523% | 3.62% | Other |
| D. E. SHAW & CO., INC. | 833,777 | 0.01% | -62.17% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 847,744 | 0.18% | New | Growth |
| BALYASNY ASSET MANAGEMENT L.P. | 355,248 | 0.01% | New | Event Driven |
| GOTHAM ASSET MANAGEMENT, LLC | 120,887 | 0.04% | -4.39% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 99,100 | 0.0016% | Exited | Other |
| AQR CAPITAL MANAGEMENT LLC | 43,377 | 0.00143% | New | Other |
| DUPONT CAPITAL MANAGEMENT CORP | 18,889 | 0.01% | Exited | Other |
| MAGNETAR FINANCIAL LLC | 12,695 | 0.00372% | New | Event Driven, Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 11,578 | 0.05% | Exited | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR TG THERAPEUTICS INC
STOCK BUYBACKS FOR TG THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2022
3.62%
1Q
09/30/2022
4.06%
2Q
03/31/2022
4.40%
4Q
12/31/2021
6.12%
5Q
09/30/2021
6.21%
6Q
06/30/2021
6.31%
7Q
03/31/2021
6.38%
8Q
09/30/2020
24.85%
10Q
06/30/2020
28.81%
11Q
03/31/2020
33.05%
12Q
Load More